The psychiatric community continues to debate the value of the US Food and Drug Administration's (FDA) so-called ‘black box’ warning on certain antidepressants, and a pair of opposing viewpoints was recently featured in the New England Journal of Medicine.
What steps should clinicians take if psychopharmacologic treatments and school behavioral strategies are insufficient for managing a child with ADHD? We've all been there. ADHD,...